Mainline Biosciences
PrivateLast Round
VC Round
Jul 1, 2024
Company Overview
Mainline Biosciences operates in Healthcare & Life Sciences and is based in Malvern, Pennsylvania. Its latest recorded funding round was a VC Round in July 2024.
Mainline Biosciences is a biotechnology company that specializes in the research and development of novel peptide-based therapeutics and peptide drug conjugates for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mainline Biosciences Comparables
Compare Mainline Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cybrexa Therapeutics | 88% | |
| ProteinQure | 83% | |
| Nanoligent | 77% |
For institutional investors. Book with your work email.
Mainline Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 1, 2024 | ||||
| Series A | Nov 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2024
Raised a VC Round with Hangzhou Taikun Equity Investment Fund Partnership.
- Nov 9, 2022
Completed a Series A funding round.
For institutional investors. Book with your work email.
Mainline Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mainline Biosciences's valuation, stock price, and market status.
Is Mainline Biosciences a public or private company?
Mainline Biosciences is a private company.
What is the current stock price of Mainline Biosciences?
Mainline Biosciences is a private company, so its shares have no public market price. Caplight tracks Mainline Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mainline Biosciences worth (valuation)?
Valuation information for Mainline Biosciences is not publicly available.
Can I buy Mainline Biosciences stock?
Mainline Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mainline Biosciences's last funding round?
Mainline Biosciences's most recent funding round was VC Round on July 1, 2024.
Who are the main investors in Mainline Biosciences?
Investor information for Mainline Biosciences is not publicly disclosed.
Will Mainline Biosciences IPO soon?
No public IPO plans have been announced for Mainline Biosciences.
How can I track Mainline Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Mainline Biosciences's shares on secondary markets.